Peitz, Ulrich <br/><br/>
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Feb 2002 
 - 315-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2002.01173.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amoxicillin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Breath Tests<br/>Clarithromycin--administration & dosage<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Nitroimidazoles--administration & dosage<br/>Omeprazole--administration & dosage<br/>Treatment Outcome